Advertisement
UK markets closed
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • FTSE 250

    19,724.05
    -75.67 (-0.38%)
     
  • AIM

    754.05
    -0.82 (-0.11%)
     
  • GBP/EUR

    1.1632
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.2430
    -0.0022 (-0.18%)
     
  • Bitcoin GBP

    52,060.84
    -1,478.38 (-2.76%)
     
  • CMC Crypto 200

    1,404.93
    -19.17 (-1.35%)
     
  • S&P 500

    5,053.79
    -16.76 (-0.33%)
     
  • DOW

    38,326.71
    -176.98 (-0.46%)
     
  • CRUDE OIL

    82.71
    -0.65 (-0.78%)
     
  • GOLD FUTURES

    2,340.00
    -2.10 (-0.09%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • CAC 40

    8,091.86
    -13.92 (-0.17%)
     

Sorrento Therapeutics' Multifaceted Plan to Attack COVID-19

Salicyn 30 is an antiviral that blocks infection of cells by the novel coronavirus. COVIDTRAP is an ACE2 receptor decoy, which could bind up the coronavirus and keep it from infecting cells. Brian Orelli: You've got a couple of other treatments that you're working on.